Working memory capacity predicts effects of methylphenidate on reversal learning

Neuropsychopharmacology

Volumn 38, Issue 10, 2013, Pages 2011-2018

  Van Der Schaaf, Marieke E ^a   Fallon, Sean J ^b   Ter Huurne, Niels ^a   Buitelaar, Jan ^c,d   Cools, Roshan ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c RADBOUD UNIVERSITY   (Netherlands)

^d RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

cognition; cognitive enhancement; dopamine; learning memory; psychostimulants; punishment; reversal learning; reward; Ritalin

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ADULT; ARTICLE; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; LEARNING; MALE; NORMAL HUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PUNISHMENT; REWARD; TASK PERFORMANCE; WORKING MEMORY;

CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HEALTHY VOLUNTEERS; HUMANS; MALE; MEMORY, SHORT-TERM; METHYLPHENIDATE; PUNISHMENT; REVERSAL LEARNING; REWARD; YOUNG ADULT;

EID: 84882455531     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.100     Document Type: Article

References (54)

1. Agay N, Yechiam E, Carmel Z, Levkovitz Y (2010). Non-specific effects of methylphenidate (Ritalin) on cognitive ability and decision-making of ADHD and healthy adults. Psychopharmacology 210: 511-519.
2. Arnsten A (1997). Catecholamine regulation of the prefrontal cortex. J Psychopharmacol 11: 151-162.
3. Barkley R (1997). Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 121: 65-159.
4. Beck A, Ward C, Mendelson M, Mock J, Erbaugh J (1961). An inventory for measuring depression. Arch Gen Psychiatry 4: 561-632.
5. Berridge K, Robinson T (1998). What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28: 309-369.
6. Bodi N, Keri S, Nagy H, Moustafa A, Myers CE, Daw N et al (2009). Reward-learning and the novelty-seeking personality: a betweenand within-subjects study of the effects of dopamine agonists on young Parkinson's patients. Brain 132(Pt 9): 2385-2395.
7. Bundt C, van Mil A, Olthof B, Reintjes W (2012). Presteren onder druk of drugs? Een interdisciplinaire academische verkenning naar cognitive enhancement. In: Radboud Honours Academy (eds) The Wider Implications of Cognitive Neuroscience, Reflections on Science 2011-2012. Radboud Honours Academy: Nijmegen.
8. Clark L, Chamberlain S, Sahakian B (2009). Neurocognitive mechanisms in depression: implications for treatment. Annu Rev Neurosci 32: 57-74.
9. Clatworthy P, Lewis S, Brichard L, Hong Y, Izquierdo D, Clark L et al (2009). Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. J Neurosci 29: 4690-4696.
10. Cools R, Altamirano L, D'Esposito M (2006). Reversal learning in Parkinson's disease depends on medication status and outcome valence. Neuropsychologia 44: 1663-1673.
11. Cools R, D'Esposito M (2011). Inverted-u-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry 69: e113-e125.
12. Cools R, Frank MJ, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M (2009). Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration. J Neurosci 29: 1538-1543.
13. Cools R, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M (2008). Working memory capacity predicts dopamine synthesis capacity in the human striatum. J Neurosci 28: 1208-1212.
14. Daneman M, Carpenter PA (1980). Individual differences in working memory and reading. J Verb Learn Verb Beh 19: 450-916.
15. DuPaul G, Power T, Anastopoulos A, Reid R (1998). ADHD Rating Scale - IV: Checklists, Norms, and Clinical Interpretation.
16. Eagle D, Tufft M, Goodchild H, Robbins T (2007). Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol. Psychopharmacology 192: 193-206.
17. Engle R, Tuholski S, Laughlin J, Conway A (1999). Working memory, short-term memory, and general fluid intelligence: a latent-variable approach. J Exp Psychol Gen 128: 309-331.
18. Faraone S, Buitelaar J (2010). Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry 19: 353-417.
19. Finke K, Dodds C, Bublak P, Regenthal R, Baumann F, Manly T et al (2010). Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study. Psychopharmacology 210: 317-329.
20. Frank M, O'Reilly R (2006). A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol. Behav Neurosci 120: 497-1014.
21. Frank MJ (2005). Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism. J Cogn Neurosci 17: 51-72.
22. Frank MJ, Santamaria A, O'Reilly RC, Willcutt E (2007). Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder. Neuropsychopharmacology 32: 1583-1599.
23. Fusar-Poli P, Rubia K, Rossi G, Sartori G, Balottin U (2012). Striatal dopamine transporter alterations in ADHD: pathophysiology or adaptation to psychostimulants? A meta-analysis. Am J Psychiatry 169: 264-272.
24. Grace A (1991). Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41: 1-25.
25. Greely H, Sahakian B, Harris J, Kessler R, Gazzaniga M, Campbell P et al (2008). Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 456: 702-705.
26. Groth-Marnat G (ed) (2001). The Wechsler Intelligence Scales. Cambridge University Press: Cambridge.
27. Hooks M, Colvin A, Juncos J, Justice J (1992). Individual differences in basal and cocaine-stimulated extracellular dopamine in the nucleus accumbens using quantitative microdialysis. Brain Res 587: 306-318.
28. Howell DC (1997). Statistical Methods for Psychology. Wadsworth Publishing Company.
29. Kimberg DY, D'Esposito M, Farah MJ (1997). Effects of bromocriptine on human subjects depend on working memory capacity. Neuroreport 8: 3581-3585.
30. Landau SM, Lal R, O'Neil JP, Baker S, Jagust WJ (2009). Striatal dopamine and working memory. Cereb Cortex 19: 445-454.
31. Maher B (2008). Poll results: look who's doping. Nature 452: 674-675.
32. Maia TV, Frank MJ (2011). From reinforcement learning models to psychiatric and neurological disorders. Nat Neurosci 14: 154-162.
33. Marcus S, Durkin M (2011). Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 50: 480-489.
34. Mehta M, Goodyer I, Sahakian B (2004). Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity. J Child Psychol Psychiatry 45: 293-598.
35. Mehta M, Owen A, Sahakian B, Mavaddat N, Pickard J, Robbins T (2000). Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 20: 6.
36. Mehta MA, Swainson R, Ogilvie AD, Sahakian J, Robbins TW (2001). Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers. Psychopharmacology 159: 10-20.
37. Oken B, Kishiyama S, Salinsky M (1995). Pharmacologically induced changes in arousal: effects on behavioral and electrophysiologic measures of alertness and attention. Electroencephalogr Clin Neurophysiol 95: 359-371.
38. Patton J, Stanford M, Barratt E (1995). Factor structure of the Barratt impulsiveness scale. J Clin Psychol 51: 768-842.
39. Robbins T (2002). ADHD and addiction. Nat Med 8: 24-29.
40. Robinson O, Cools R, Carlisi C, Sahakian B, Drevets W (2011). Ventral striatum response during reward and punishment reversal learning in unmedicated major depressive disorder. Am J Psychiatry 169: 152-159.
41. Schmand B, Bakker D, Saan R, Louman J (1991). The Dutch Reading Test for Adults: a measure of premorbid intelligence level. Tijdschr Gerontol Geriatr 22: 15-24.
42. Schmedtje J, Oman C, Letz R, Baker E (1988). Effects of scopolamine and dextroamphetamine on human performance. Aviat Space Environ Med 59: 407-410.
43. Sheehan D, Lecrubier Y, Sheehan K, Amorim P, Janavs J, Weiller E et al (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20): 22-33.
44. Silber B, Croft R, Papafotiou K, Stough C (2006). The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance. Psychopharmacology 187: 154-169.
45. Smith M, Farah M (2011). Are prescription stimulants ''smart pills''? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol Bull 137: 717-741.
46. Spielberger G, Gorsuch RL, Lushene RE (1970). Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press: Palo Alto, CA, USA.
47. Swanson J, Gupta S, Lam A, Shoulson I, Lerner M, Modi N et al (2003). Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies. Arch Gen Psychiatry 60: 204-215.
48. van der Schaaf M, van Schouwenburg M, Geurts D, Schellekens A, Buitelaar J, Verkes R et al (2012). Establishing the dopamine dependency of human striatal signals during reward and punishment reversal learning. Cereb Cortex (e-pub ahead of print, doi:10.1093/cercor/bhs344).
49. Volkow N, Wang G-J, Fowler J, Logan J, Franceschi D, Maynard L et al (2002). Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse 43: 181-188.
50. Volkow N, Wang G-J, Fowler J, Telang F, Maynard L, Logan J et al (2004). Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry 161: 1173-1180.
51. Volkow N, Wang G-J, Kollins S, Wigal T, Newcorn J, Telang F et al (2009). Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA 302: 1084-1091.
52. Volkow N, Wang G-J, Tomasi D, Kollins S, Wigal T, Newcorn J et al (2012). Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder. J Neurosci 32: 841-850.
53. Voon V, Pessiglione M, Brezing C, Gallea C, Fernandez HH, Dolan RJ et al (2010). Mechanisms underlying dopaminemediated reward bias in compulsive behaviors. Neuron 65: 135-142.
54. Wigal S, Wigal T, Schuck S, Brams M, Williamson D, Armstrong R et al (2011). Academic, behavioral, and cognitive effects of OROSs methylphenidate on older children with attentiondeficit/ hyperactivity disorder. J Child Adolesc Psychopharmacol 21: 121-131..